Adial Pharmaceuticals Inc. (NASDAQ: ADIL) jumped 21.19%  after the company announced plans to foray into the genetic testing market following the grant of a Notice of Allowance from the US patent and Trademark Office (USPTO).  Adial receives a patent related to AD04 The patent notice is related to using the […]